Trials / Completed
CompletedNCT00497913
Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether a single injection of Dysport with a new protocol at forearm is effective in the management of chronic lateral epicondylitis.
Detailed description
Some studies valued the effectiveness of botulinum toxin. There is a great amount of controversy on the amount of botulinum toxin injected and the location of the injection. The purpose of the study is to compare the effectiveness of botulinum toxin injection with placebo at a new injection site at the forearm in the treatment of chronic tennis elbow unrelieved by corticosteroid injection and physiotherapy. It is a double blind randomized controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NaCl 0.9% | |
| DRUG | Botulinum Toxin A |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-03-01
- Completion
- 2008-04-01
- First posted
- 2007-07-09
- Last updated
- 2008-04-23
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00497913. Inclusion in this directory is not an endorsement.